SQZ Biotechnologies

Cell therapy company developing treatments by engineering immune cells using its proprietary Cell Squeeze technology platform, which mechanically deforms cells to enable intracellular delivery of therapeutic payloads. Publicly traded on NYSE (SQZ).

Location
Watertown, Massachusetts, USA
Founded
2013
Investors
1
Categories
biotech, cell-therapy, immunotherapy, public-company, platform

Investors

NameLocationTypeStagesPortfolio
Polaris PartnersUSbiotech-focused-33